These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 19145874
21. Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study. Alexandropoulou K, van Vlymen J, Reid F, Poullis A, Kang JY. Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):15-21. PubMed ID: 23022985 [Abstract] [Full Text] [Related]
22. Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a placebo-controlled treatment-withdrawal study in infants 1-11 months old with symptomatic GERD. Winter H, Kum-Nji P, Mahomedy SH, Kierkus J, Hinz M, Li H, Maguire MK, Comer GM. J Pediatr Gastroenterol Nutr; 2010 Jun; 50(6):609-18. PubMed ID: 20400912 [Abstract] [Full Text] [Related]
24. [Pharmacokinetics of the proton pump inhibitors and psychological status in patients as factors that influence the efficiency of treatment of GERD with pantoprazole]. Bordin DS, Masharova AA, Sil'vestrova SIu, Firsova LD, Safonova OV, Petrakov AV, Kozhurina TS, Valitova ER, Ianova OB. Eksp Klin Gastroenterol; 2010 Jul; (9):90-6. PubMed ID: 21427932 [Abstract] [Full Text] [Related]
25. Pantoprazole available without a prescription: new status. Better than H2 receptor agonists, but not for pregnant women. Prescrire Int; 2009 Dec; 18(104):250. PubMed ID: 20025090 [Abstract] [Full Text] [Related]
26. Predicting the efficacy of proton pump inhibitors in patients with non-erosive reflux disease before therapy using dual-channel 24-h esophageal pH monitoring. Shimatani T, Sugimoto M, Nishino M, Adachi K, Furuta K, Ito M, Kurosawa S, Manabe N, Mannen K, Hongo M, Chiba T, Kinoshita Y, Acid-Related Symptom Research (ARS) Group. J Gastroenterol Hepatol; 2012 May; 27(5):899-906. PubMed ID: 22098590 [Abstract] [Full Text] [Related]
27. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations. Devault KR. Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):197-205. PubMed ID: 19072410 [Abstract] [Full Text] [Related]
28. Ask the doctor. Do PPI drugs for stomach acid reduce the risk of cancer in people (like me) with Barrett's esophagus? Komaroff AL. Harv Health Lett; 2014 Apr; 39(6):2. PubMed ID: 24873004 [No Abstract] [Full Text] [Related]
29. A 59-year-old woman with gastroesophageal reflux disease and barrett esophagus, 4 years later. Burns RB. JAMA; 2006 Nov 01; 296(17):2140. PubMed ID: 17077379 [No Abstract] [Full Text] [Related]
30. Clinical practice. Barrett's esophagus. Sharma P. N Engl J Med; 2009 Dec 24; 361(26):2548-56. PubMed ID: 20032324 [No Abstract] [Full Text] [Related]
31. High-dose esomeprazole for treatment of symptomatic refractory gastroesophageal reflux disease--a prospective pH-metry/impedance-controlled study. Bajbouj M, Becker V, Phillip V, Wilhelm D, Schmid RM, Meining A. Digestion; 2009 Dec 24; 80(2):112-8. PubMed ID: 19641320 [Abstract] [Full Text] [Related]
32. Eosinophilic esophagitis and gastroesophageal reflux disease: there and back again. Hirano I. Clin Gastroenterol Hepatol; 2011 Feb 24; 9(2):99-101. PubMed ID: 21070874 [No Abstract] [Full Text] [Related]
33. On-demand proton pump inhibitory treatment in overweight/obese patients with gastroesophageal reflux disease: are there pharmacodynamic arguments for using higher doses? Bruley des Varannes S, Coudsy B, Waechter S, Delemos B, Xiang J, Lococo J, Ducrotté P. Digestion; 2013 Feb 24; 88(1):56-63. PubMed ID: 23880545 [Abstract] [Full Text] [Related]
34. Dexlansoprazole MR: a review. Hershcovici T, Jha LK, Fass R. Ann Med; 2011 Aug 24; 43(5):366-74. PubMed ID: 21366513 [Abstract] [Full Text] [Related]
35. [The role of esophageal manometry in the management of the patients with gastro-esophageal reflux disease and Barrett's esophagus]. Hoară P, Bîrlă R, Gîndea C, Constantin A, Panaitescu G, Iordan N, Constantinoiu S. Chirurgia (Bucur); 2008 Aug 24; 103(4):407-12. PubMed ID: 18780613 [Abstract] [Full Text] [Related]
36. Treatment of GERD and proton pump inhibitor use in the elderly: practical approaches and frequently asked questions. Scholl S, Dellon ES, Shaheen NJ. Am J Gastroenterol; 2011 Mar 24; 106(3):386-92. PubMed ID: 21378759 [No Abstract] [Full Text] [Related]
37. [Focus on multi-morbidity patients. Considering the greatest measure of therapy safety]. MMW Fortschr Med; 2007 Dec 06; 149(49-50):59. PubMed ID: 18236986 [No Abstract] [Full Text] [Related]
38. Cough syncope induced by gastroesophageal reflux disease. Kusuyama T, Iida H, Kino N, Shimodozono S, Kanazawa Y. J Cardiol; 2009 Oct 06; 54(2):300-3. PubMed ID: 19782269 [Abstract] [Full Text] [Related]
39. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy? Beaumont H, Boeckxstaens GE. Am J Gastroenterol; 2009 Jul 06; 104(7):1764-71. PubMed ID: 19491837 [Abstract] [Full Text] [Related]
40. Clinical symptoms of FSSG in gastroesophageal reflux disease are critical for PPI treatment: Japanese multi-centers with 185 patients. Komatsu-Tanaka M, Iwakiri R, Fujimoto K, Fujiwara Y, Inamori M, Tanaka J, Shimatani T, Akiyama J, Ando T, Manabe N, Kinjo F, Deguchi R, Kusano M. Dig Endosc; 2012 Nov 06; 24(6):407-11. PubMed ID: 23078431 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]